{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:54:29Z","timestamp":1785333269821,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T00:00:00Z","timestamp":1309219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00392-011-0338-8","type":"journal-article","created":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T04:25:23Z","timestamp":1309235123000},"page":"1037-1043","source":"Crossref","is-referenced-by-count":25,"title":["Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty"],"prefix":"10.1007","volume":"100","author":[{"given":"Michal","family":"Droppa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Desch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Blase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Eitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Fuernau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,28]]},"reference":[{"issue":"19","key":"338_CR1","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.CIR.0000016043.87291.33","volume":"105","author":"CS Rihal","year":"2002","unstructured":"Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105(19):2259\u20132264. doi: 10.1161\/01.CIR.0000016043.87291.33","journal-title":"Circulation"},{"issue":"22","key":"338_CR2","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/01.CIR.0000103623.63687.21","volume":"108","author":"HM Sadeghi","year":"2003","unstructured":"Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, Fahy M, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Stuckey TD, Turco M, Carroll JD (2003) Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108(22):2769\u20132775. doi: 10.1161\/01.CIR.0000103623.63687.21","journal-title":"Circulation"},{"issue":"12","key":"338_CR3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00392-009-0058-5","volume":"98","author":"I Wickenbrock","year":"2009","unstructured":"Wickenbrock I, Perings C, Maagh P, Quack I, van Bracht M, Prull MW, Plehn G, Trappe HJ, Meissner A (2009) Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI. Clin Res Cardiol 98(12):765\u2013772. doi: 10.1007\/s00392-009-0058-5","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"338_CR4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1540-8183.2010.00581.x","volume":"23","author":"E Chong","year":"2010","unstructured":"Chong E, Poh KK, Liang S, Soon CY, Tan HC (2010) Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions. J Interv Cardiol 23(5):451\u2013459. doi: 10.1111\/j.1540-8183.2010.00581.x","journal-title":"J Interv Cardiol"},{"key":"338_CR5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1741-7015-2-38","volume":"2","author":"SM Bagshaw","year":"2004","unstructured":"Bagshaw SM, Ghali WA (2004) Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis. BMC Med 2:38. doi: 10.1186\/1741-7015-2-38","journal-title":"BMC Med"},{"issue":"12","key":"338_CR6","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0735-1097(03)00487-X","volume":"41","author":"CS Baker","year":"2003","unstructured":"Baker CS, Wragg A, Kumar S, De Palma R, Baker LR, Knight CJ (2003) A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41(12):2114\u20132118. doi: 10.1016\/S0735-1097(03)00487-X","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"338_CR7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ehj.2003.11.016","volume":"25","author":"C Briguori","year":"2004","unstructured":"Briguori C, Colombo A, Violante A, Balestrieri P, Manganelli F, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Focaccio A, Librera M, Bonizzoni E, Ricciardelli B (2004) Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 25(3):206\u2013211. doi: 10.1016\/j.ehj.2003.11.016","journal-title":"Eur Heart J"},{"key":"338_CR8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1741-7015-5-32","volume":"5","author":"DA Gonzales","year":"2007","unstructured":"Gonzales DA, Norsworthy KJ, Kern SJ, Banks S, Sieving PC, Star RA, Natanson C, Danner RL (2007) A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC Med 5:32. doi: 10.1186\/1741-7015-5-32","journal-title":"BMC Med"},{"issue":"14","key":"338_CR9","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1161\/CIRCULATIONAHA.105.595090","volume":"113","author":"M Tepel","year":"2006","unstructured":"Tepel M, Aspelin P, Lameire N (2006) Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 113(14):1799\u20131806. doi: 10.1161\/CIRCULATIONAHA.105.595090","journal-title":"Circulation"},{"issue":"3","key":"338_CR10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","volume":"343","author":"M Tepel","year":"2000","unstructured":"Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W (2000) Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343(3):180\u2013184. doi: 10.1056\/NEJM200007203430304","journal-title":"N Engl J Med"},{"issue":"20","key":"338_CR11","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jacc.2009.08.091","volume":"55","author":"H Thiele","year":"2010","unstructured":"Thiele H, Hildebrand L, Schirdewahn C, Eitel I, Adams V, Fuernau G, Erbs S, Linke A, Diederich KW, Nowak M, Desch S, Gutberlet M, Schuler G (2010) Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention The LIPSIA-N-ACC (prospective, single-blind, placebo-controlled, randomized leipzig Immediate percutaneous coronary intervention acute myocardial infarction N-ACC) trial. J Am Coll Cardiol 55(20):2201\u20132209. doi: 10.1016\/j.jacc.2009.08.091","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"338_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00392-007-0486-z","volume":"96","author":"B Scheller","year":"2007","unstructured":"Scheller B (2007) How to protect from contrast media-induced nephropathy? Clin Res Cardiol 96(3):125\u2013129. doi: 10.1007\/s00392-007-0486-z","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"338_CR13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00392-007-0473-4","volume":"96","author":"H Reinecke","year":"2007","unstructured":"Reinecke H, Fobker M, Wellmann J, Becke B, Fleiter J, Heitmeyer C, Breithardt G, Hense HW, Schaefer RM (2007) A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the dialysis-versus-diuresis (DVD) Trial. Clin Res Cardiol 96(3):130\u2013139. doi: 10.1007\/s00392-007-0473-4","journal-title":"Clin Res Cardiol"},{"key":"338_CR14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0065-2423(01)35015-1","volume":"35","author":"AO Grubb","year":"2000","unstructured":"Grubb AO (2000) Cystatin C\u2014properties and use as diagnostic marker. Adv Clin Chem 35:63\u201399. doi: 10.1016\/S0065-2423(01)35015-1","journal-title":"Adv Clin Chem"},{"issue":"2","key":"338_CR15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","volume":"40","author":"VR Dharnidharka","year":"2002","unstructured":"Dharnidharka VR, Kwon C, Stevens G (2002) Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40(2):221\u2013226. doi: 10.1053\/ajkd.2002.34487","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"338_CR16","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1523-1755.2004.00861.x","volume":"66","author":"S Herget-Rosenthal","year":"2004","unstructured":"Herget-Rosenthal S, Marggraf G, Husing J, Goring F, Pietruck F, Janssen O, Philipp T, Kribben A (2004) Early detection of acute renal failure by serum cystatin C. Kidney Int 66(3):1115\u20131122. doi: 10.1111\/j.1523-1755.2004.00861.x","journal-title":"Kidney Int"},{"issue":"1","key":"338_CR17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ki.1995.40","volume":"47","author":"DJ Newman","year":"1995","unstructured":"Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP (1995) Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 47(1):312\u2013318. doi: 10.1038\/ki.1995.40","journal-title":"Kidney Int"},{"issue":"2","key":"338_CR18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5414\/CNP61098","volume":"61","author":"H Rickli","year":"2004","unstructured":"Rickli H, Benou K, Ammann P, Fehr T, Brunner-La Rocca HP, Petridis H, Riesen W, Wuthrich RP (2004) Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol 61(2):98\u2013102","journal-title":"Clin Nephrol"},{"issue":"4","key":"338_CR19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/0003-4819-145-4-200608150-00003","volume":"145","author":"MG Shlipak","year":"2006","unstructured":"Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS (2006) Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145(4):237\u2013246 pii: 145\/4\/237","journal-title":"Ann Intern Med"},{"issue":"3","key":"338_CR20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.amjcard.2009.03.059","volume":"104","author":"CY Campbell","year":"2009","unstructured":"Campbell CY, Clarke W, Park H, Haq N, Barone BB, Brotman DJ (2009) Usefulness of cystatin C and prognosis following admission for acute heart failure. Am J Cardiol 104(3):389\u2013392. doi: 10.1016\/j.amjcard.2009.03.059","journal-title":"Am J Cardiol"},{"issue":"11","key":"338_CR21","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1002\/clc.20465","volume":"32","author":"R Deo","year":"2009","unstructured":"Deo R, Shlipak MG, Ix JH, Ali S, Schiller NB, Whooley MA (2009) Association of cystatin C with ischemia in patients with coronary heart disease. Clin Cardiol 32(11):E18\u2013E22. doi: 10.1002\/clc.20465","journal-title":"Clin Cardiol"},{"issue":"11","key":"338_CR22","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/clc.20672","volume":"32","author":"C Ge","year":"2009","unstructured":"Ge C, Ren F, Lu S, Ji F, Chen X, Wu X (2009) Clinical prognostic significance of plasma cystatin C levels among patients with acute coronary syndrome. Clin Cardiol 32(11):644\u2013648. doi: 10.1002\/clc.20672","journal-title":"Clin Cardiol"},{"issue":"4","key":"338_CR23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/STROKEAHA.109.573162","volume":"41","author":"M Hoke","year":"2010","unstructured":"Hoke M, Amighi J, Mlekusch W, Schlager O, Exner M, Sabeti S, Dick P, Koppensteiner R, Minar E, Rumpold H, Wagner O, Schillinger M (2010) Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Stroke 41(4):674\u2013679. doi: 10.1161\/STROKEAHA.109.573162","journal-title":"Stroke"},{"issue":"2","key":"338_CR24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/CIRCULATIONAHA.106.644286","volume":"115","author":"JH Ix","year":"2007","unstructured":"Ix JH, Shlipak MG, Chertow GM, Whooley MA (2007) Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 115(2):173\u2013179. doi: 10.1161\/CIRCULATIONAHA.106.644286","journal-title":"Circulation"},{"issue":"3","key":"338_CR25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/eurheartj\/ehn598","volume":"30","author":"T Keller","year":"2009","unstructured":"Keller T, Messow CM, Lubos E, Nicaud V, Wild PS, Rupprecht HJ, Bickel C, Tzikas S, Peetz D, Lackner KJ, Tiret L, Munzel TF, Blankenberg S, Schnabel RB (2009) Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study. Eur Heart J 30(3):314\u2013320. doi: 10.1093\/eurheartj\/ehn598","journal-title":"Eur Heart J"},{"issue":"2","key":"338_CR26","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.atherosclerosis.2009.05.015","volume":"207","author":"T Kilic","year":"2009","unstructured":"Kilic T, Oner G, Ural E, Yumuk Z, Sahin T, Bildirici U, Acar E, Celikyurt U, Kozdag G, Ural D (2009) Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome. Atherosclerosis 207(2):552\u2013558. doi: 10.1016\/j.atherosclerosis.2009.05.015","journal-title":"Atherosclerosis"},{"issue":"12","key":"338_CR27","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.amjcard.2009.02.029","volume":"103","author":"S Manzano-Fernandez","year":"2009","unstructured":"Manzano-Fernandez S, Boronat-Garcia M, Albaladejo-Oton MD, Pastor P, Garrido IP, Pastor-Perez FJ, Martinez-Hernandez P, Valdes M, Pascual-Figal DA (2009) Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Am J Cardiol 103(12):1753\u20131759. doi: 10.1016\/j.amjcard.2009.02.029","journal-title":"Am J Cardiol"},{"issue":"3","key":"338_CR28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jjcc.2009.06.003","volume":"54","author":"H Sekizuka","year":"2009","unstructured":"Sekizuka H, Akashi YJ, Kawasaki K, Yamauchi M, Musha H (2009) Cystatin C: a better marker to detect coronary artery sclerosis. J Cardiol 54(3):359\u2013367. doi: 10.1016\/j.jjcc.2009.06.003","journal-title":"J Cardiol"},{"issue":"11","key":"338_CR29","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1373\/clinchem.2009.128397","volume":"55","author":"N Taglieri","year":"2009","unstructured":"Taglieri N, Koenig W, Kaski JC (2009) Cystatin C and cardiovascular risk. Clin Chem 55(11):1932\u20131943. doi: 10.1373\/clinchem.2009.128397","journal-title":"Clin Chem"},{"issue":"1","key":"338_CR30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.107.747642","volume":"118","author":"H Thiele","year":"2008","unstructured":"Thiele H, Schindler K, Friedenberger J, Eitel I, Furnau G, Grebe E, Erbs S, Linke A, Mobius-Winkler S, Kivelitz D, Schuler G (2008) Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation 118(1):49\u201357. doi: 10.1161\/CIRCULATIONAHA.107.747642","journal-title":"Circulation"},{"issue":"3","key":"338_CR31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2008.08.013","volume":"138","author":"BJ Kim","year":"2010","unstructured":"Kim BJ, Sung KC, Kim BS, Kang JH, Lee KB, Kim H, Lee MH (2010) Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial. Int J Cardiol 138(3):239\u2013245. doi: 10.1016\/j.ijcard.2008.08.013","journal-title":"Int J Cardiol"},{"issue":"3","key":"338_CR32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2214\/AJR.07.2356","volume":"189","author":"PA Poletti","year":"2007","unstructured":"Poletti PA, Saudan P, Platon A, Mermillod B, Sautter AM, Vermeulen B, Sarasin FP, Becker CD, Martin PY (2007) I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. AJR Am J Roentgenol 189(3):687\u2013692. doi: 10.2214\/AJR.07.2356","journal-title":"AJR Am J Roentgenol"},{"key":"338_CR33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.me.39.020188.002341","volume":"39","author":"AS Levey","year":"1988","unstructured":"Levey AS, Perrone RD, Madias NE (1988) Serum creatinine and renal function. Annu Rev Med 39:465\u2013490. doi: 10.1146\/annurev.me.39.020188.002341","journal-title":"Annu Rev Med"},{"issue":"10","key":"338_CR34","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/clinchem\/38.10.1933","volume":"38","author":"RD Perrone","year":"1992","unstructured":"Perrone RD, Madias NE, Levey AS (1992) Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 38(10):1933\u20131953","journal-title":"Clin Chem"},{"issue":"5","key":"338_CR35","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ki.1985.205","volume":"28","author":"O Shemesh","year":"1985","unstructured":"Shemesh O, Golbetz H, Kriss JP, Myers BD (1985) Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28(5):830\u2013838. doi: 10.1038\/ki.1985.205","journal-title":"Kidney Int"},{"issue":"4","key":"338_CR36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/ndt\/gfh707","volume":"20","author":"EA Hoste","year":"2005","unstructured":"Hoste EA, Damen J, Vanholder RC, Lameire NH, Delanghe JR, Van den Hauwe K, Colardyn FA (2005) Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant 20(4):747\u2013753. doi: 10.1093\/ndt\/gfh707","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"338_CR37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.ASN.0000106780.14856.55","volume":"15","author":"U Hoffmann","year":"2004","unstructured":"Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK (2004) The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15(2):407\u2013410. doi: 10.1097\/01.ASN.0000106780.14856.55","journal-title":"J Am Soc Nephrol"},{"issue":"19","key":"338_CR38","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1161\/CIRCULATIONAHA.109.919639","volume":"121","author":"C Briguori","year":"2010","unstructured":"Briguori C, Visconti G, Rivera NV, Focaccio A, Golia B, Giannone R, Castaldo D, De Micco F, Ricciardelli B, Colombo A (2010) Cystatin C and contrast-induced acute kidney injury. Circulation 121(19):2117\u20132122. doi: 10.1161\/CIRCULATIONAHA.109.919639","journal-title":"Circulation"},{"issue":"2","key":"338_CR39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.atherosclerosis.2007.09.022","volume":"198","author":"G Niccoli","year":"2008","unstructured":"Niccoli G, Conte M, Della Bona R, Altamura L, Siviglia M, Dato I, Ferrante G, Leone AM, Porto I, Burzotta F, Brugaletta S, Biasucci LM, Crea F (2008) Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate. Atherosclerosis 198(2):373\u2013380. doi: 10.1016\/j.atherosclerosis.2007.09.022","journal-title":"Atherosclerosis"},{"issue":"2","key":"338_CR40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1373\/clinchem.2004.041889","volume":"51","author":"W Koenig","year":"2005","unstructured":"Koenig W, Twardella D, Brenner H, Rothenbacher D (2005) Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 51(2):321\u2013327. doi: 10.1373\/clinchem.2004.041889","journal-title":"Clin Chem"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-011-0338-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-011-0338-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-011-0338-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T22:15:16Z","timestamp":1592691316000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-011-0338-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,28]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["338"],"URL":"https:\/\/doi.org\/10.1007\/s00392-011-0338-8","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,28]]}}}